Retraction
Combined RNAi targeting human Stat3 and ADAM9 as gene therapy for non-small cell lung cancer
Paper Information
Record ID:
41131
Author(s):
Journal:
Publication Date:
December 09, 2015
Retraction Date:
November 14, 2022
(3.0 years years ago)
Subjects:
Institution:
Department of Thoracic Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. ChinaCountry:
🇨🇳 ChinaArticle Type:
Publisher:
Spandidos
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.3892/ol.2022.13595Additional Notes:
see also: https://pubpeer.com/publications/6CC72611D898A306E422E7D283C8EB
Citations (12)
12
Total Citations0
Post-Retraction12
Pre-Retraction0
Same DayPotential Molecular Biomarkers of Vestibular Schwannoma Growth: Progress and Prospects
Yu Zhang, Jianfei Long, Junwei Ren et al. (6 authors)
Frontiers in Oncology
Open Access
Published: Sep 2021
26 citations
26 citations
413 days before retraction
Combinatorial Low Dose Arsenic Trioxide and Cisplatin Exacerbates Autophagy via AMPK/STAT3 Signaling on Targeting Head and Neck Cancer Initiating Cells
Wei-Chun Hu, Wan‐Huai Teo, Tung-Fu Huang et al. (5 authors)
Frontiers in Oncology
Open Access
Published: Apr 2020
19 citations
19 citations
943 days before retraction
Research Progress of ADAM9 in the Biology of Solid Tumors
莉金 朱
Advances in Clinical Medicine
Published: Jan 2020
1048 days before retraction
Cytochalasin H Inhibits Angiogenesis <i>via</i> the Suppression of HIF-1α Protein Accumulation and VEGF Expression through PI3K/AKT/P70S6K and ERK1/2 Signaling Pathways in Non-Small Cell Lung Cancer Cells
Yuefan Ma, Zihan Xiu, Zhiyuan Zhou et al. (8 authors)
Journal of Cancer
Open Access
Published: Jan 2019
20 citations
20 citations
1413 days before retraction
MicroRNA-425 promotes the development of lung adenocarcinoma via targeting A disintegrin and metalloproteinases 9 (ADAM9)
Ruibao Liu, Fang Wang, Yanchun Guo et al. (7 authors)
OncoTargets and Therapy
Open Access
Published: Jul 2018
12 citations
12 citations
1597 days before retraction
Preparation, characterization, in vitro and in vivo anti-tumor effect of thalidomide nanoparticles on lung cancer
LongXia Chen, XiaoLing Ni, Heng Zhang et al. (9 authors)
International Journal of Nanomedicine
Open Access
Published: Apr 2018
20 citations
20 citations
1688 days before retraction
Jak/STAT Signaling in Head and Neck Cancer
Elizabeth Cedars, Daniel E. Johnson, Jennifer R. Grandis
Current cancer research
Published: Jan 2018
3 citations
3 citations
1778 days before retraction
ADAM protein family – its role in tumorigenesis, mechanisms of chemoresistance and potential as diagnostic and prognostic factors
Łukasz Zadka, Michał Kulus, Katarzyna Piątek
Neoplasma
Open Access
Published: Jan 2018
13 citations
13 citations
1778 days before retraction
Recent developments in nanomedicine for melanoma treatment
Jianqin Tang, Xiao‐Yang Hou, Chun‐Sheng Yang et al. (9 authors)
International Journal of Cancer
Open Access
Published: Mar 2017
44 citations
44 citations
2060 days before retraction
Combination of Solamargine and Metformin Strengthens IGFBP1 Gene Expression Through Inactivation of Stat3 and Reciprocal Interaction Between FOXO3a and SP1
Qing Tang, Fang Zheng, Jingjing Wu et al. (6 authors)
Cellular Physiology and Biochemistry
Open Access
Published: Jan 2017
19 citations
19 citations
2143 days before retraction
Synergistic action of cisplatin and echistatin in MDA-MB-231 breast cancer cells
Robert Czarnomysy, Arkadiusz Surażyński, Bożena Popławska et al. (8 authors)
Molecular and Cellular Biochemistry
Open Access
Published: Dec 2016
24 citations
24 citations
2156 days before retraction
Optimal Design for Informative Protocols in Xenograft Tumor Growth Inhibition Experiments in Mice
Giulia Lestini, France Mentré, Paolo Magni
The AAPS Journal
Open Access
Published: Jun 2016
11 citations
11 citations
2343 days before retraction
Quick Stats
Total Citations:
12
Years Since Retraction:
3.0 years
Open Access:
Yes
Last Checked:
Jul 24, 2025